Enfusion Statistics
Share Statistics
Enfusion has 94.8M
shares outstanding. The number of shares has increased by 3.15%
in one year.
| Shares Outstanding | 94.8M |
| Shares Change (YoY) | 3.15% |
| Shares Change (QoQ) | 0.46% |
| Owned by Institutions (%) | 98.11% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 331 |
| FTD / Avg. Volume | 0.03% |
Short Selling Information
The latest short interest is 1.3M, so 1.37% of the outstanding
shares have been sold short.
| Short Interest | 1.3M |
| Short % of Shares Out | 1.37% |
| Short % of Float | 2.83% |
| Short Ratio (days to cover) | 1.57 |
Valuation Ratios
The PE ratio is 335.84 and the forward
PE ratio is 29.08.
Enfusion's PEG ratio is
-4.14.
| PE Ratio | 335.84 |
| Forward PE | 29.08 |
| PS Ratio | 4.7 |
| Forward PS | 3.3 |
| PB Ratio | 12.95 |
| P/FCF Ratio | 30.54 |
| PEG Ratio | -4.14 |
Financial Ratio HistoryEnterprise Valuation
Enfusion has an Enterprise Value (EV) of 913.9M.
| EV / Sales | 4.53 |
| EV / EBITDA | 148.48 |
| EV / EBIT | 26.35 |
| EV / FCF | 29.44 |
Financial Position
The company has a current ratio of 3.42,
with a Debt / Equity ratio of 0.28.
| Current Ratio | 3.42 |
| Quick Ratio | 3.42 |
| Debt / Equity | 0.28 |
| Debt / EBITDA | 3.3 |
| Debt / FCF | 0.65 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is 3.86% and Return on Invested Capital is 1.93%.
| Return on Equity | 3.86% |
| Return on Assets | 1.97% |
| Return on Invested Capital | 1.93% |
| Revenue Per Employee | $176,387.58 |
| Profits Per Employee | $2,469.82 |
| Employee Count | 1,143 |
| Asset Turnover | 1.41 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 4.57M |
| Effective Tax Rate | 61.79% |
Stock Price Statistics
The stock price has increased by 14.23% in the
last 52 weeks. The beta is 0.93, so Enfusion's
price volatility has been higher than the market average.
| Beta | 0.93 |
| 52-Week Price Change | 14.23% |
| 50-Day Moving Average | 11.1 |
| 200-Day Moving Average | 9.83 |
| Relative Strength Index (RSI) | 42.68 |
| Average Volume (20 Days) | 1,164,473 |
Income Statement
In the last 12 months, Enfusion had revenue of 201.61M
and earned 2.82M
in profits. Earnings per share was 0.02.
| Revenue | 201.61M |
| Gross Profit | 136.74M |
| Operating Income | 6.16M |
| Net Income | 2.82M |
| EBITDA | 6.16M |
| EBIT | 6.16M |
| Earnings Per Share (EPS) | 0.02 |
Full Income StatementBalance Sheet
The company has 54.48M in cash and 20.31M in
debt, giving a net cash position of 34.17M.
| Cash & Cash Equivalents | 54.48M |
| Total Debt | 20.31M |
| Net Cash | 34.17M |
| Retained Earnings | -170.11M |
| Total Assets | 143.26M |
| Working Capital | 66.19M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 34.68M
and capital expenditures -3.63M, giving a free cash flow of 31.05M.
| Operating Cash Flow | 34.68M |
| Capital Expenditures | -3.63M |
| Free Cash Flow | 31.05M |
| FCF Per Share | 0.34 |
Full Cash Flow StatementMargins
Gross margin is 67.82%, with operating and profit margins of 3.05% and 1.4%.
| Gross Margin | 67.82% |
| Operating Margin | 3.05% |
| Pretax Margin | 3.66% |
| Profit Margin | 1.4% |
| EBITDA Margin | 3.05% |
| EBIT Margin | 3.05% |
| FCF Margin | 15.4% |
